Zacks Investment Research Lowers LONZA GROUP AG UNSP ADR EACH REP 0.1 (LZAGY) to Hold
According to Zacks, “Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The company’s Life Science Ingredients segment produces nutrition ingredients for applications in nutrition (food, feed and pharmaceutical application) and chemical intermediates for the agricultural industry. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics. Lonza Group AG is headquartered in Basel, Switzerland. “
LONZA GROUP AG UNSP ADR EACH REP 0.1 (NASDAQ:LZAGY) opened at 18.79 on Wednesday. The stock has a market cap of $9.85 billion and a PE ratio of 26.92. LONZA GROUP AG UNSP ADR EACH REP 0.1 has a 12-month low of $12.83 and a 12-month high of $19.65. The firm has a 50-day moving average price of $18.99 and a 200-day moving average price of $17.40.
About LONZA GROUP AG UNSP ADR EACH REP 0.1
Receive News & Ratings for LONZA GROUP AG UNSP ADR EACH REP 0.1 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LONZA GROUP AG UNSP ADR EACH REP 0.1 and related companies with MarketBeat.com's FREE daily email newsletter.